219 related articles for article (PubMed ID: 18636786)
1. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
Tamim H; Duranceau A; Chen LQ; Lelorier J
Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
[TBL] [Abstract][Full Text] [Related]
2. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.
Eom CS; Park SM; Myung SK; Yun JM; Ahn JS
Ann Fam Med; 2011; 9(3):257-67. PubMed ID: 21555754
[TBL] [Abstract][Full Text] [Related]
3. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
[TBL] [Abstract][Full Text] [Related]
4. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
5. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.
Ahn JS; Eom CS; Jeon CY; Park SM
World J Gastroenterol; 2013 Apr; 19(16):2560-8. PubMed ID: 23674860
[TBL] [Abstract][Full Text] [Related]
6. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
7. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
8. Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
Lin HC; Huang KT; Lin HL; Uang YS; Ho Y; Keller JJ; Wang LH
PLoS One; 2021; 16(3):e0249050. PubMed ID: 33765029
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for falls with use of acid-suppressive drugs.
Cea-Soriano L; Johansson S; García Rodríguez LA
Epidemiology; 2013 Jul; 24(4):600-7. PubMed ID: 23676267
[TBL] [Abstract][Full Text] [Related]
10. [Adverse effects of gastric acid suppressive drugs].
Haruma K; Kamada T; Shiotani A
Nihon Rinsho; 2007 Oct; 65 Suppl 8():198-201. PubMed ID: 18074539
[No Abstract] [Full Text] [Related]
11. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.
Corley DA; Kubo A; Zhao W; Quesenberry C
Gastroenterology; 2010 Jul; 139(1):93-101. PubMed ID: 20353792
[TBL] [Abstract][Full Text] [Related]
13. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer risk in relation to use of acid suppressive medications.
Chubak J; Boudreau DM; Rulyak SJ; Mandelson MT
Pharmacoepidemiol Drug Saf; 2009 Jul; 18(7):540-4. PubMed ID: 19367565
[TBL] [Abstract][Full Text] [Related]
15. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting.
Cea Soriano L; Ruigómez A; Johansson S; García Rodríguez LA
Pharmacotherapy; 2014 Jun; 34(6):570-81. PubMed ID: 24634193
[TBL] [Abstract][Full Text] [Related]
16. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.
Waldum HL; Sørdal Ø; Fossmark R
Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782
[TBL] [Abstract][Full Text] [Related]
19. Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study.
Hsu WH; Kuo CH; Wang SS; Lu CY; Liu CJ; Chuah SK; Kuo FC; Chen YH; Huang YB; Hou MF; Wu DC; Hu HM
BMC Gastroenterol; 2014 May; 14():91. PubMed ID: 24884853
[TBL] [Abstract][Full Text] [Related]
20. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]